ENDPOINTS

AstraZeneca earmarks $2.5B for first vaccine factory and second R&D site in China

AstraZeneca is again boosting its manufacturing footprint in China, this time spending a $2.5 billion investment to build its first vaccine plant and second R&D facility in the country. As a part of the investment ...

Mar 21, 2025 - 16:25
 0
AstraZeneca earmarks $2.5B for first vaccine factory and second R&D site in China
AstraZeneca is again boosting its manufacturing footprint in China, this time spending a $2.5 billion investment to build its first vaccine plant and second R&D facility in the country. As a part of the investment ...
Read More

Tags:

Previous Article

AstraZeneca broadens presence in China, promising $8B+ to Harbour and Syneron

Next Article

Akeso shares new data for bispecific in cervical cancer; Pulmatrix to divest assets

Related Posts

DOGE shutters lease on FDA lab in St. Louis and 29 other sites

DOGE shutters lease on FDA lab in St. Louis and 29 othe...

Mar 4, 2025  0

Inside the Accolade-Transcarent deal

Inside the Accolade-Transcarent deal

Feb 20, 2025  0

Trump’s science crackdown hits rare disease research: ‘We need to sit down with Elon Musk’

Trump’s science crackdown hits rare disease research: ‘...

Feb 28, 2025  0